Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of a Partially Supervised Conditioning Program in CF: an International Multi-centre, Randomized Controlled Trial
Brief Summary: Physical activity and exercise have become an accepted and valued component of Cystic Fibrosis care. Regular physical activity and exercise can slow the rate of decline of pulmonary function, improve physical fitness, and enhance quality of life. However, motivating people to be more active is challenging. Supervised exercise programs are expensive and labor intensive, and adherence falls off significantly once supervision ends. Unsupervised or partially supervised programs are less costly and more flexible, but compliance can be more problematic. The primary objective of this study is to evaluate the effects of a 12-months partially supervised exercise intervention along with regular motivation on forced expiratory volume in 1 second (FEV1) in a large international group of cystic fibrosis patients. Secondary endpoints include patient reported quality of life, as well as levels of anxiety and depression, and control of blood sugar. A total of 292 patients with cystic fibrosis 12 years and older with a FEV1 ≥35% predicted will be recruited. Following baseline assessments (2 visits) patients will be randomized into an intervention and a control group. Thereafter, they will be seen every 3 months for assessments in their centre for one year (4 follow-up visits). Along with individual counseling to increase vigorous physical activity by at least 3 hours per week on each clinic visit, the intervention group will document daily exercise and inactivity time and will receive a step counter and they will record their progress with a web-based program. They will also receive monthly phone calls from the study staff. After 6 months, they will continue with the step counter and web-based program for a further 6 months. The control group will receive access to this intervention after 12 months of standardized care. Should this relatively simple program prove successful, this will be made available on a wider scale internationally.


Options:
A: Arm Label: Comprehensive Adherence Program (CAP); Type: EXPERIMENTAL; Interventions: Behavioral: Comprehensive Adherence Program (CAP) | Arm Label: Standard Care (SC); Type: EXPERIMENTAL; Interventions: Behavioral: Comprehensive Adherence Program (CAP) | Intervention Type: BEHAVIORAL; Name: Comprehensive Adherence Program (CAP); Assigned to Arm(s): Comprehensive Adherence Program (CAP), Standard Care (SC)
B: Arm Label: Exercise Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Exercise Intervention
C: Arm Label: Placebo (pooled two times a day [BID]/three times a day [TID]); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo two times a day (BID)/three times a day (TID) | Arm Label: AZLI (pooled two times a day [BID]/three times a day [TID]); Type: EXPERIMENTAL; Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID) | Intervention Type: DRUG; Name: AZLI 75 mg two times a day (BID)/three times a day (TID); Assigned to Arm(s): AZLI (pooled two times a day [BID]/three times a day [TID]) | Intervention Type: DRUG; Name: Placebo two times a day (BID)/three times a day (TID); Assigned to Arm(s): Placebo (pooled two times a day [BID]/three times a day [TID])
D: Arm Label: All meds but depression, 1x daily use, RxTimerCap; Type: EXPERIMENTAL; Interventions: Behavioral: RxTimerCap | Arm Label: All meds but depression, 1x daily use, Take-N-Slide; Type: EXPERIMENTAL; Interventions: Behavioral: Take-N-Slide | Arm Label: All meds but depression, 1x daily use, pillbox; Type: EXPERIMENTAL; Interventions: Behavioral: Pillbox | Arm Label: All meds but depression, 1x daily use, control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: All meds but depression, ≥1 med >1 daily use, RxTimerCap; Type: EXPERIMENTAL; Interventions: Behavioral: RxTimerCap | Arm Label: All meds but depression, ≥1 med >1 daily use, pillbox; Type: EXPERIMENTAL; Interventions: Behavioral: Pillbox | Arm Label: All meds but depression, ≥1 med >1 daily use, control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Only depression meds, 1x daily use, RxTimerCap; Type: EXPERIMENTAL; Interventions: Behavioral: RxTimerCap | Arm Label: Only depression meds, 1x daily use, Take-N-Slide; Type: EXPERIMENTAL; Interventions: Behavioral: Take-N-Slide | Arm Label: Only depression meds, 1x daily use, pillbox; Type: EXPERIMENTAL; Interventions: Behavioral: Pillbox | Arm Label: Only depression meds, 1x daily use, control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Only depression meds, ≥1 med >1 daily use, RxTimerCap; Type: EXPERIMENTAL; Interventions: Behavioral: RxTimerCap | Arm Label: Only depression meds, ≥1 med >1 daily use, pillbox; Type: EXPERIMENTAL; Interventions: Behavioral: Pillbox | Arm Label: Only depression meds, ≥1 med >1 daily use, control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: RxTimerCap; Assigned to Arm(s): All meds but depression, 1x daily use, RxTimerCap, All meds but depression, ≥1 med >1 daily use, RxTimerCap, Only depression meds, 1x daily use, RxTimerCap, Only depression meds, ≥1 med >1 daily use, RxTimerCap | Intervention Type: BEHAVIORAL; Name: Take-N-Slide; Assigned to Arm(s): All meds but depression, 1x daily use, Take-N-Slide, Only depression meds, 1x daily use, Take-N-Slide | Intervention Type: BEHAVIORAL; Name: Pillbox; Assigned to Arm(s): All meds but depression, 1x daily use, pillbox, All meds but depression, ≥1 med >1 daily use, pillbox, Only depression meds, 1x daily use, pillbox, Only depression meds, ≥1 med >1 daily use, pillbox

Answer: B